Development of Sjogren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C

Journal of Gastroenterology

Volumn 31, Issue 5, 1996, Pages 723-727

  Unoki, Hideaki ^a   Moriyama, Atsushi ^a   Tabaru, Akinari ^a   Masumoto, Akihide ^a   Otsuki, Makoto ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Chronic hepatitis C; Hypergammaglobulinemia; Interferon alpha 2b; Side effect; Sjogren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN; RECOMBINANT ALPHA2B INTERFERON; ALPHA2B INTERFERON;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DRY EYE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEPATITIS C; HUMAN; LACRIMAL GLAND FUNCTION; PRIORITY JOURNAL; SALIVARY GLAND FUNCTION; SIALOGRAPHY; SJOEGREN SYNDROME; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY;

BIOPSY, NEEDLE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 0029658334     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02347624     Document Type: Article

References (17)

1. Berris B, Feinman SV. Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 1991;36:1657-1660.
2. Akard LP, Hoffman R. Alpha-interferon and immune hemolytic anemia. Ann Int Med 1986;105:306.
3. Ueno Y, Sohma T. Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann Int Med 1992,117:266-267.
4. Chazerain P, Meyer O, Kahn MF. Rheumatoid arthritis-like disease after alpha-interferon therapy. Ann Int Med 1992;116:427.
5. Schattner A. Review: Interferons and autoimmunity. Am J Med Sci 1988;295:523-544.
6. Review by an International Group. Acute and chronic hepatitis revisited. Lancet 1977;II:914-919.
7. Oto M, et al. Report from the Study Group of Sjögren's syndrome supported by the Japanese Ministry of Health and Welfare (in Japanese). 1978:3-6.
8. Kessler HS. A laboratory model for Sjögren's syndrome. Am J Pathol 1968;52:671-678.
9. Minato N, Reid L, Cantor H, et al. Mode of regulation of natural killer activity by Interferon. J Exp Med 1980;152:124-137.
10. Herberman B, Ortaldo R, Mantovani A, et al. Effect of human recombinant Interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol 1982;67:160-167.
11. Levinson I, Dziarski A, Hooks J. Modulation of polyclonal B cell differentiation by human leukocyte alpha interferon. Clin Exp Immunol 1982,49:677-683.
12. Vento S, Perri DG, Garofano T, et al. Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 1989; 11:926.
13. Saito I, Servenious B, Compton T, et al. Detection of Epstein- Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 1989;169:2191-2198.
14. Green J, Hinrichs S, Vogel J, et al. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature 1989;341:72-74.
15. Marriette X, Zerbib M, Jaccard A, et al. Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum 1993;36:280-281.
16. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.
17. Ohta M, IShill Y, Takami S, et al. A case of autoimmune hepatitis developed with interferon treatment (in Japanese with English abstract). Jpn J Gastroenterol 1991;88:209-212.